Astellas Pharma Licenses Promising Gene Therapy KT430 from Kate Therapeutics Amidst Clinical Hurdles
FDA AdComm Narrowly Supports Approval Of Sarepta's Gene Therapy For Rare Neuromuscular Disorder
Astellas Pharma Licenses Promising Gene Therapy KT430 from Kate Therapeutics Amidst Clinical Hurdles
FDA AdComm Narrowly Supports Approval Of Sarepta's Gene Therapy For Rare Neuromuscular Disorder
$2M Price Tag for Sickle Cell Gene Therapies Could Be Cost-Effective Under Certain Scenarios, Finds ICER Analysis
6 Questions With Rocket Pharma's CEO On World Health Day: How The Biotech Is 'Changing The Narrative'
$2M Price Tag for Sickle Cell Gene Therapies Could Be Cost-Effective Under Certain Scenarios, Finds ICER Analysis
6 Questions With Rocket Pharma's CEO On World Health Day: How The Biotech Is 'Changing The Narrative'
Tesla, Meta, Thermogenesis, Adobe, UiPath: Why These 5 Stocks Are Drawing Investors' Attention Today
Regenxbio Says Diabetic Retinopathy Gene Therapy Shows Meaningful Improvements In Disease Severity
Gene Therapy Recent News
What Happened With Ocugen Shares During Wednesday's After-Hours Session
This COVID-19 Shot Stock Could Have Eye Disease Gene Therapy As Significant Driver, Mizuho Analyst Says
Bluebird's Gene Therapy Scores US Approval For Genetic Blood Disorder, Probably The Most Expensive
Homology Medicines Announces Preclinical Gene Therapy Candidate For Genetic Storage Disorder
This Penny Stock Touts Encouraging Long-Term Data For Hemophilia Gene Therapy
Adverum Posts New Data From Wet AMD Gene Therapy Trial
Sarepta Reports One Heart Inflammation Case In Duchenne Gene Therapy Trial
MeiraGTx Posts Encouraging Gene Therapy Data From Eye Disorder Trial
Astellas's Pompe Disease Gene Therapy Trial Put On FDA Clinical Hold
UniQure Shares Are Up After Low-Dose Cohort Data From Huntington's Gene Therapy Trial
BMO Capital Says Risk/Reward For This Gene Stock Assumes Clinical Success
Analysts Consider CRISPR Therapeutics' Blood Disorder Trial Data Encouraging, Impressive
Mizuho Comments On UniQure's Upcoming Low-Dose Huntington's Gene Therapy Trial Data
Mustang Bio Posts Encouraging Interim Data From Gene Therapy Trial In Immunodeficiency
Rocket Pharma's Gene Therapy Shows 100% Overall Survival In Immune Deficiency Disorder
Avrobio's Pompe Disease Gene Therapy Shows Efficacy, Safety In Preclinical Study
AVROBIO Shares Jumps On Encouraging Data From Early-Stage Gene Therapy Study
The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation
Applied Genetic's Vision Loss Gene Therapy Shows Encouraging Safety, Efficacy At Three Months
Adverum Bio Posts Additional Efficacy, Safety Data From ADVM-022 Gene Therapy In Wet AMD
FDA Gives Green Signal To Pfizer's Duchenne Gene Therapy Trial
Monitoring Board Gives Positive Recommendation On Ocugen's Eye Disease Gene Therapy Trial
Amicus Shares Encouraging Long-Term Data Of AT-GAA Study In Pompe Disease